Zhenyu Ou

1.6k total citations
45 papers, 1.1k citations indexed

About

Zhenyu Ou is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zhenyu Ou has authored 45 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 16 papers in Molecular Biology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zhenyu Ou's work include Bladder and Urothelial Cancer Treatments (18 papers), Cancer-related molecular mechanisms research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Zhenyu Ou is often cited by papers focused on Bladder and Urothelial Cancer Treatments (18 papers), Cancer-related molecular mechanisms research (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Zhenyu Ou collaborates with scholars based in China, United States and Taiwan. Zhenyu Ou's co-authors include Shuyuan Yeh, Chawnshang Chang, Jinbo Chen, Lin Qi, Xiongbing Zu, Yin Sun, Long Wang, Longfei Liu, Jiao Hu and Huihuang Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Zhenyu Ou

44 papers receiving 1.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Zhenyu Ou 504 366 287 281 182 45 1.1k
Shreyas Joshi 408 0.8× 188 0.5× 552 1.9× 259 0.9× 376 2.1× 91 1.2k
Paula L. Hyland 450 0.9× 149 0.4× 156 0.5× 145 0.5× 164 0.9× 43 940
Mojgan Asgari 471 0.9× 250 0.7× 262 0.9× 178 0.6× 331 1.8× 61 1.0k
Yosuke Morizawa 295 0.6× 126 0.3× 382 1.3× 571 2.0× 416 2.3× 143 1.3k
Yasuhide Kitagawa 437 0.9× 103 0.3× 326 1.1× 177 0.6× 249 1.4× 61 1.1k
Jian Pan 214 0.4× 111 0.3× 338 1.2× 231 0.8× 176 1.0× 52 836
H. Heynemann 261 0.5× 209 0.6× 385 1.3× 226 0.8× 316 1.7× 48 825
Kazuhiro Nagao 312 0.6× 144 0.4× 296 1.0× 377 1.3× 235 1.3× 83 877
Catherine Dowling 425 0.8× 193 0.5× 331 1.2× 160 0.6× 368 2.0× 37 1.0k
Jeffrey Reese 168 0.3× 130 0.4× 276 1.0× 437 1.6× 170 0.9× 25 851

Countries citing papers authored by Zhenyu Ou

Since Specialization
Citations

This map shows the geographic impact of Zhenyu Ou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyu Ou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyu Ou more than expected).

Fields of papers citing papers by Zhenyu Ou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenyu Ou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyu Ou. The network helps show where Zhenyu Ou may publish in the future.

Co-authorship network of co-authors of Zhenyu Ou

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenyu Ou. A scholar is included among the top collaborators of Zhenyu Ou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenyu Ou. Zhenyu Ou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Lingxiao, Cheng He, Zhenyu Ou, & Cheng Zhao. (2025). TNF-α drives bladder cancer metastasis via METTL3-mediated m6A modification to promote CLASP2/IQGAP1-dependent cytoskeleton remodeling. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1871(5). 167811–167811. 4 indexed citations
2.
Xiang, Jie, Yukai Li, Zhenyu Ou, et al.. (2025). Novel diagnostic and therapeutic strategies based on PANoptosis for hepatocellular carcinoma. Cancer Biology and Medicine. 22(8). 1–12. 5 indexed citations
3.
Chen, Jinbo, Chi‐Ping Huang, Chao Quan, et al.. (2023). The androgen receptor in bladder cancer. Nature Reviews Urology. 20(9). 560–574. 29 indexed citations
4.
Ou, Zhenyu, Peihua Liu, Zhao Cheng, et al.. (2023). ATXN3 promotes prostate cancer progression by stabilizing YAP. Cell Communication and Signaling. 21(1). 152–152. 11 indexed citations
5.
6.
Li, Huihuang, Jinbo Chen, Zhenghao Li, et al.. (2023). S100A5 Attenuates Efficiency of Anti‐PD‐L1/PD‐1 Immunotherapy by Inhibiting CD8+ T Cell‐Mediated Anti‐Cancer Immunity in Bladder Carcinoma. Advanced Science. 10(25). e2300110–e2300110. 32 indexed citations
7.
Liu, Peihua, Belaydi Othmane, Jiao Hu, et al.. (2022). m6A-induced lncDBET promotes the malignant progression of bladder cancer through FABP5-mediated lipid metabolism. Theranostics. 12(14). 6291–6307. 51 indexed citations
8.
Yang, Zhongqing, et al.. (2022). SOX5 promotes cell growth and migration through modulating DNMT1/p21 pathway in bladder cancer. Acta Biochimica et Biophysica Sinica. 54(7). 987–998. 4 indexed citations
9.
Yi, Zhenglin, Zhenyu Ou, Jiao Hu, et al.. (2022). Computer-aided diagnosis of prostate cancer based on deep neural networks from multi-parametric magnetic resonance imaging. Frontiers in Physiology. 13. 918381–918381. 9 indexed citations
10.
Li, Huihuang, Jiao Hu, Xiongbing Zu, et al.. (2022). A novel signature to predict the neoadjuvant chemotherapy response of bladder carcinoma: Results from a territory multicenter real-world study. Frontiers in Genetics. 13. 1047481–1047481. 1 indexed citations
11.
Zhang, Chunyu, Jiao Hu, Huihuang Li, et al.. (2021). Emerging Biomarkers for Predicting Bladder Cancer Lymph Node Metastasis. Frontiers in Oncology. 11. 648968–648968. 15 indexed citations
12.
Zhang, Mengda, Lin Qi, Xiongbing Zu, et al.. (2019). ERα-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion. Cell Death and Disease. 10(9). 635–635. 33 indexed citations
14.
Zhou, Xu, Yu Cui, Jinbo Chen, et al.. (2019). UCA1 promotes cell viability, proliferation and migration potential through UCA1/miR-204/CCND2 pathway in primary cystitis glandularis cells. Biomedicine & Pharmacotherapy. 114. 108872–108872. 10 indexed citations
15.
Zhang, Junjie, Zhenyu Ou, Xiaobo Zhang, et al.. (2019). Holmium laser enucleation of the prostate versus thulium laser enucleation of the prostate for the treatment of large-volume prostates > 80 ml: 18-month follow-up results. World Journal of Urology. 38(6). 1555–1562. 48 indexed citations
16.
Ou, Zhenyu, Yongjie Wang, Jinbo Chen, et al.. (2018). Estrogen receptor β promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals. Experimental & Molecular Medicine. 50(11). 1–11. 45 indexed citations
17.
Ding, Jie, Chiuan‐Ren Yeh, Yin Sun, et al.. (2018). Estrogen receptor β promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network. Oncogene. 37(37). 5037–5053. 90 indexed citations
18.
Qi, Lin, Sulai Liu, Wentao Liu, et al.. (2017). CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor. BMC Cancer. 17(1). 105–105. 17 indexed citations
19.
Wang, Yongjun, et al.. (2016). Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals. Oncogene. 36(12). 1644–1654. 45 indexed citations
20.
Ou, Zhenyu, Lin Qi, Jinrui Yang, et al.. (2013). Preliminary Experience and Learning Curve for Laparoendoscopic Single-Site Retroperitoneal Pyeloplasty. Journal of Laparoendoscopic & Advanced Surgical Techniques. 23(9). 765–770. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026